ARCHIVES

Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says

This article is from The Cancer Letter archive.

Vol. 24 No. 24 | June 19, 1998

Download PDF Visit The Full Archive

Related Articles

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

NCI program announcement available, contract awards listed.

November 14, 2003

Review Of Organ Site Program Requested By NCAB Set For Nov. 23-25; Eight Member Committee Named

August 21, 1981

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

Former NCI, FDA Chief Andrew Von Eschenbach Appointed to NCCN Foundation Board

June 17, 2011

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003